Synthesis and biological evaluation of (±)-benzhydrol derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitors

被引:7
|
作者
Ma, Xiao-Dong [1 ]
Zhang, Xuan [4 ,5 ]
Yang, Shi-Qiong [1 ]
Dai, Hui-Fang [3 ]
Yang, Liu-Meng [4 ]
Gu, Shuang-Xi [1 ]
Zheng, Yong-Tang [4 ]
He, Qiu-Qin [1 ]
Chen, Fen-Er [1 ,2 ]
机构
[1] Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China
[2] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China
[3] Fudan Univ, Sch Pharm, Shanghai 200031, Peoples R China
[4] Chinese Acad Sci, Kunming Inst Zool, Chinese Acad Sci & Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Peoples R China
[5] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China
基金
上海市自然科学基金; 中国国家自然科学基金;
关键词
HIV; NNRTIs; Benzophenone derivatives; Benzhydrol; SAR; PROTEIN-BINDING SITES; MOLECULAR DOCKING; SEARCH; BENZOPHENONES; RESISTANCE; DISCOVERY; INFECTION; GW678248; NNRTIS;
D O I
10.1016/j.bmc.2011.07.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of (+/-)-benzhydrol derivatives featuring the essential sulfonamide group at the para position on the C-ring were synthesized and evaluated for the potential anti-HIV activity in C8166 cells. Most of these analogues demonstrated low concentration inhibitory activity with EC50 values less than 1 mu M against the wild-type HIV-1. In particular, compound 7h was identified as the highest active inhibitor of wildtype HIV-1 with an EC50 value of 0.12 mu M and selectivity index value of 312.73. Furthermore, some of them also exhibited moderate activity against the double mutant strain A(17) (K103N + Y181C) with EC50 values lower than 5 mu M. In addition, the binding modes with RT and the preliminary structure-activity relationships of these derivatives were also explored for further chemical modifications. Crown Copyright (C) 2011 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:4704 / 4709
页数:6
相关论文
共 50 条
  • [1] Halolactones are potent HIV-1 non-nucleoside reverse transcriptase inhibitors
    Han, Xin
    Wu, Haoming
    Dong, Chune
    Tien, Po
    Xie, Wei
    Wu, Shuwen
    Zhou, Hai-Bing
    RSC ADVANCES, 2015, 5 (13): : 10005 - 10013
  • [2] Non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis and biological evaluation of novel quinoxalinylethylpyridylthioureas as potent antiviral agents
    Campiani, G
    Fabbrini, M
    Morelli, E
    Nacci, V
    Greco, G
    Novellino, E
    Maga, G
    Spadari, S
    Bergamini, A
    Faggioli, E
    Uccella, I
    Bolacchi, F
    Marini, S
    Coletta, M
    Fracasso, C
    Caccia, S
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 2000, 11 (02): : 141 - 155
  • [3] Design, Synthesis, and Evaluation of Diarylpyridines and Diarylanilines as Potent Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors
    Tian, Xingtao
    Qin, Bingjie
    Wu, Zhiyuan
    Wang, Xiaofeng
    Lu, Hong
    Morris-Natschke, Susan L.
    Chen, Chin Ho
    Jiang, Shibo
    Lee, Kuo-Hsiung
    Xie, Lan
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (23) : 8287 - 8297
  • [4] Synthesis and biological evaluation of piperidine-substituted triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors
    Chen, Xuwang
    Zhan, Peng
    Pannecouque, Christophe
    Balzarini, Jan
    De Clercq, Erik
    Liu, Xinyong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 51 : 60 - 66
  • [5] Non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Proudfoot, JR
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1998, 8 (08) : 971 - 982
  • [6] HIV-1 non-nucleoside reverse transcriptase inhibitors
    Högberg, M
    Morrison, I
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (08) : 1189 - 1199
  • [7] Rational Design of Potent Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase
    Chong, Pek
    Sebahar, Paul
    Youngman, Michael
    Garrido, Dulce
    Zhang, Huichang
    Stewart, Eugene L.
    Nolte, Robert T.
    Wang, Liping
    Ferris, Robert G.
    Edelstein, Mark
    Weaver, Kurt
    Mathis, Amanda
    Peat, Andrew
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (23) : 10601 - 10609
  • [8] Synthesis and biological evaluation of CHX-DAPYs as HIV-1 non-nucleoside reverse transcriptase inhibitors
    Yan, Zi-Hong
    Wu, Hai-Qiu
    Chen, Wen-Xue
    Wu, Yan
    Piao, Hu-Ri
    He, Qiu-Qin
    Chen, Fen-Er
    De Clercq, Erik
    Pannecouque, Christophe
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (12) : 3220 - 3226
  • [9] Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
    Zhan, Peng
    Liu, Xinyong
    Zhu, Junjie
    Fang, Zengjun
    Li, Zhenyu
    Pannecouque, Christophe
    De Clercq, Erik
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (16) : 5775 - 5781
  • [10] Synthesis and biological evaluations of sulfanyltriazoles as novel HIV-1 non-nucleoside reverse transcriptase inhibitors
    Wang, Zhiwei
    Wu, Baogen
    Kuhen, Kelli L.
    Bursulaya, Badry
    Nguyen, Truc N.
    Nguyen, Deborah G.
    He, Yun
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (16) : 4174 - 4177